Tezepelumab was linked to significantly reduced nasal polyp size and nasal congestion vs placebo in adults with severe CRSwNP.

In this randomized controlled trial, among patients with severe, uncontrolled chronic rhinosinusitis with nasal polyps, tezepelumab more effectively reduced nasal polyp size and sinonasal symptoms ...

A new CT-scan based risk score facilitates the identification of patients at risk of revision endoscopic sinus surgery due to ...

A new CT-scan-based risk score facilitates the identification of patients at risk of revision endoscopic sinus surgery due to ...

A nasal endoscopy may also be performed to diagnose nasal polyps. This procedure uses a long, flexible tube with a light on the end that is inserted into the nose and sinuses to look for potential ...

The need for systemic corticosteroids fell by 88%, and the need for surgery fell by 98%. Nasal polyp and congestion scores fell, along with loss of smell and total symptom scores. SAN DIEGO ...

Dr. Palasis continued, “At the same time, we continue to be encouraged about the positive post-hoc data analyses in the CRS patient cohort with nasal polyps, including the ... and have not had prior ...

A decision to proceed with nasal polyp surgery was recorded in just 0.5% of tezepelumab-treated patients compared to 22.1% in the placebo group (hazard ratio, 0.02). Systemic glucocorticoid use ...

some patients experience recurrent polyps leading to repeated procedures,” Sanna Toppila-Salmi, MD, and colleagues wrote. However, data on the factors that predict revisional endoscopic sinus surgery ...

Results from a drug trial showed AstraZeneca and Amgen's new drug Tezspire significantly reduced nasal polyp severity, the need for surgery and anti-inflammatory steroid use in patients with ...